Potassium iodide tabs
Ended Awarded Last action
- Contract number
- SPE2DR26FMJS3
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $123,255
Award facts
- Contract value 100% obligated
- $123,255.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $123.3K delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for potassium iodide tablets. The contract, designated as delivery order 4570846349, is structured as a firm fixed-price agreement with an ultimate completion date of January 26, 2026, and utilizes no set-aside designation. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $30.3 billion acquisition strategy designed to support recurring pharmaceutical supply needs across Department of Defense healthcare facilities worldwide.
DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, leveraging its small business status to compete effectively in unrestricted federal procurement. The company's comprehensive product portfolio spans branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, and specialty pharmaceuticals, enabling it to fulfill diverse medical requirements for military healthcare operations globally. Under the broader PPV-G GEN V contract framework—which features a 30-month base period with three 30-month option periods extending through December 2036—DMS Pharmaceutical Group continues to demonstrate consistent performance across multiple delivery orders issued by the Defense Logistics Agency's Medical Supply Chain division.
Quick answers
Who was awarded contract SPE2DR26FMJS3?
SPE2DR26FMJS3 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 23, 2026.
How much is contract SPE2DR26FMJS3 worth?
The government has obligated $123,255 on SPE2DR26FMJS3.
Is contract SPE2DR26FMJS3 an order under another contract?
Yes. SPE2DR26FMJS3 is a delivery order under SPE2DR25D9901, an indefinite delivery contract.
Was contract SPE2DR26FMJS3 competed?
The extent of competition for SPE2DR26FMJS3 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award